Screener
10x Genomics, Inc. TXG Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use assets | 56,685 | 60,450 |
| Goodwill | 6,918 | 4,511 |
| Intangible assets, net | 61,160 | 62,329 |
| Other noncurrent assets | 15,308 | 2,913 |
| Total assets | $1,030,066 | $1,041,365 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $20,694 | $12,733 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s deferred tax assets and other non-current assets?
- 10x Genomics, Inc. (TXG) reported deferred tax assets and other non-current assets of $15.31M in Q2 2026.
- How has 10x Genomics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- 10x Genomics, Inc.'s deferred tax assets and other non-current assets increased by 472.5% year-over-year, from $2.67M to $15.31M.
- What is the long-term trend for 10x Genomics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s deferred tax assets and other non-current assets has grown at a -7.6% compound annual growth rate (CAGR), from $4.32M to $2.91M.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about 10x Genomics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude